{
    "query": "21",
    "resultCount": 5,
    "source": "kingbrand.com\/Studies.php",
    "results": [
        {
            "studyNumber": 39,
            "shortTitle": "Efficacy of Platelet-Rich Plasma Versus Placebo in the Treatment of Tendinopathy",
            "fullTitle": "Efficacy of Platelet-Rich Plasma Versus Placebo in the Treatment of Tendinopathy: A Systematic Review and Meta-analysis of Randomized Controlled Trials",
            "authors": "Chen X, Jones IA, Park C, Vangsness CT Jr.",
            "journal": "American Journal of Sports Medicine (2021)",
            "summary": "This systematic review and meta-analysis evaluated randomized controlled trials comparing PRP injections to placebo in the treatment of tendinopathy. The pooled analysis revealed no significant differences in pain relief or functional improvement at various time points (4-6 weeks, 12 weeks, and 24 weeks or longer) between the PRP and placebo groups. The study concluded that PRP injections were not superior to placebo in managing tendinopathy.",
            "pubmedUrl": "https:\/\/pubmed.ncbi.nlm.nih.gov\/34342296\/"
        },
        {
            "studyNumber": 63,
            "shortTitle": "Early Versus Delayed Rehabilitation After Rotator Cuff Repair Shows No Clear Benefit",
            "fullTitle": "Effectiveness of early versus delayed rehabilitation following rotator cuff repair: Systematic review and meta-analyses.",
            "authors": "Mazuquin B, Moffatt M, Gill P, Selfe J, Rees J, Drew S, Littlewood C",
            "journal": "PLoS One (2021)",
            "summary": "This systematic review and meta-analysis examined 20 randomized controlled trials involving 1,841 patients to compare early versus delayed rehabilitation after rotator cuff repair. The study found no significant differences between the two approaches in terms of pain, function, strength, or repair integrity at any follow-up time point. Early rehabilitation provided slightly better range of motion in the short term, but this did not translate into better long-term outcomes. The findings support that delaying aggressive rehabilitation does not harm recovery, and that patients can benefit from a more conservative approach that prioritizes rest and protection of the healing tissue.",
            "pubmedUrl": "https:\/\/pubmed.ncbi.nlm.nih.gov\/34048450\/"
        },
        {
            "studyNumber": 74,
            "shortTitle": "Retear Rates After Rotator Cuff Repair Range From 13 to 94 Percent",
            "fullTitle": "Re-tears after rotator cuff repair: Current concepts review.",
            "authors": "Mandaleson A",
            "journal": "Journal of Clinical Orthopaedics and Trauma (2021)",
            "summary": "This comprehensive review examined the rates and risk factors for retear after rotator cuff repair surgery. The author found that retear rates following surgical repair range from 13% to 94%, despite patients often reporting satisfactory clinical outcomes. Multiple factors contribute to retear risk, including patient age, tear size and morphology, surgical technique, and rehabilitation approach. The high variability in retear rates demonstrates that healing after rotator cuff repair is fragile and far from guaranteed. These findings support the importance of protecting the repaired tendon from excessive stress during recovery and the need for ongoing care long after the initial pain subsides.",
            "pubmedUrl": "https:\/\/pubmed.ncbi.nlm.nih.gov\/34123722\/"
        },
        {
            "studyNumber": 75,
            "shortTitle": "Immobilization Causes Rapid Muscle Strength Loss and Atrophy",
            "fullTitle": "Nonuniform loss of muscle strength and atrophy during bed rest: a systematic review.",
            "authors": "Marusic U, Narici M, Simunic B, Pisot R, Ritzmann R",
            "journal": "Journal of Applied Physiology (2021)",
            "summary": "This systematic review analyzed data from 318 healthy adults across studies of bed rest lasting 5 to 120 days to quantify how quickly muscles weaken and shrink during inactivity. The researchers found that muscle strength declines rapidly during the earliest stages of immobilization, with the greatest rate of loss occurring in the first few days. Notably, strength declined much faster than muscle size, with strength loss outpacing atrophy by a factor of 4.2 on day 5. Approximately 79% of strength loss could be explained by muscle atrophy, while the remainder was due to neural and cellular changes. These findings demonstrate that even short periods of inactivity can significantly weaken muscles, supporting the need to maintain circulation and prevent atrophy during recovery from injury.",
            "pubmedUrl": "https:\/\/pubmed.ncbi.nlm.nih.gov\/33703945\/"
        },
        {
            "studyNumber": 88,
            "shortTitle": "Ibuprofen 400 mg Is as Effective as Higher Doses for Pain Relief",
            "fullTitle": "Analgesic effect of oral ibuprofen 400, 600, and 800 mg; paracetamol 500 and 1000 mg; and paracetamol 1000 mg plus 60 mg codeine in acute postoperative pain: a single-dose, randomized, placebo-controlled, and double-blind study.",
            "authors": "Lyngstad G, Skjelbred P, Swanson DM, Skoglund LA",
            "journal": "European Journal of Clinical Pharmacology (2021)",
            "summary": "This randomized, double-blind, placebo-controlled study compared the pain-relieving effectiveness of different doses of ibuprofen and other common pain medications in 350 patients after third molar surgery. Patients received either ibuprofen at 400 mg, 600 mg, or 800 mg, paracetamol at 500 mg or 1000 mg, a paracetamol-codeine combination, or a placebo. The researchers measured pain intensity over 6 hours, time to pain relief, duration of effectiveness, and the number of patients needing additional medication. The key finding was that ibuprofen doses above 400 mg did not significantly increase pain relief. In other words, taking 600 mg or 800 mg of ibuprofen provides essentially the same benefit as taking 400 mg, but with a higher dose that increases the risk of side effects. All active ibuprofen doses were similarly effective, and adverse effects were low and mild across all groups. This study directly supports the recommendation that 400 mg of ibuprofen is a sufficient dose for effective pain and inflammation relief. Taking more does not provide additional benefit but does increase exposure and risk, particularly to the gastrointestinal system. This finding validates a low-dose strategy that maximizes therapeutic benefit while minimizing the potential for harm.",
            "pubmedUrl": "https:\/\/pubmed.ncbi.nlm.nih.gov\/34655316\/"
        }
    ]
}